Company: BIAF
Filing Date: 2025-07-15
Form Type: 8-K
Source: 0001641172-25-019714
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-07-15
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events.

On
July 15, 2025, bioAffinity Technologies, Inc., a Delaware corporation, (the “ Company”) issued a press release announcing
it has received notification of allowance from the China National Intellectual Property Administration (CNIPA) for a patent application
related to methods of predicting the likelihood of lung cancer using flow cytometry.

The
newly allowed Chinese patent titled “ System and Method for Determining Lung Health” protects the use of defined antibodies
and the porphyrin TCPP to label cell populations in sputum and the use of flow cytometry to determine the presence of lung cancer cells
in the sputum.

A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.